Document is current
Any future updates will be listed below
-
Authors
Carrasco-Zanini, Julia https://orcid.org/0000-0002-3988-7505
Pietzner, Maik https://orcid.org/0000-0003-3437-9963
Davitte, Jonathan
Surendran, Praveen
Croteau-Chonka, Damien C. https://orcid.org/0000-0003-3466-1846
Robins, Chloe
Torralbo, Ana
Tomlinson, Christopher https://orcid.org/0000-0002-0903-5395
Grünschläger, Florian
Fitzpatrick, Natalie
Ytsma, Cai https://orcid.org/0000-0002-8333-6428
Kanno, Tokuwa
Gade, Stephan
Freitag, Daniel
Ziebell, Frederik
Haas, Simon https://orcid.org/0000-0001-9227-2051
Denaxas, Spiros
Betts, Joanna C.
Wareham, Nicholas J. https://orcid.org/0000-0003-1422-2993
Hemingway, Harry https://orcid.org/0000-0003-2279-0624
Scott, Robert A. https://orcid.org/0000-0003-3634-3016
Langenberg, Claudia https://orcid.org/0000-0002-5017-7344
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_PC_21036, MR/N003284/1 and MC_UU_00006/1 and MC_PC_21036)
Wellcome Trust (220044/Z/19/Z)
Cancer Research UK (C864/A14136)
- License Information
-
More Information
Article History
Received: 26 October 2023
Accepted: 19 June 2024
First Online: 22 July 2024
Competing interests
: J.D., P.S., D.C.C.-C., C.R., T.K., S.G., D.F., F.Z., J.B. and R.A.S. are all employees of and/or shareholders of GSK. The remaining authors declare no competing interests.
